Pfizer and Schlumberger Are January Bounce Candidates
Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31
Morgan Stanley Sticks to Their Hold Rating for Pfizer (PFE)
S&P 500, Dow Hit Records Right After Open | Live Stock
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Hong Kong stocks fluctuate | Zai Lab (09688) rises over 5% as it cooperates with Pfizer on the new antibacterial drug in mainland China.
zai lab (09688) rose more than 5%, as of the deadline, it increased by 5.26%, closing at 20.8 Hong Kong dollars, with a turnover of 7.8692 million Hong Kong dollars.
loading...
Albert kwok : CEO Albert bot at 24.8